IM Cannabis (IMCC) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Achieved revenue of C$54.7 million for 2025, demonstrating stability amid challenges in Israel.
Generated positive operating cash flow of C$4.7 million, a turnaround from negative cash flow in 2024.
Germany revenue grew over 134% year-over-year to C$36.3 million, now over 66% of total revenue.
Announced intent to diversify into defense and intelligence technology sectors via proposed acquisition in Poland.
Financial highlights
Gross profit increased 15% to C$9.7 million, driven by cost efficiencies and higher-margin German sales.
Cash and restricted cash rose to C$3.3 million from C$927,000 at year-end 2024.
Strengthened cash position through a private placement yielding net proceeds of C$5.1 million.
Outlook and guidance
Exploring additional business activities to enhance long-term growth, including entry into defense and homeland security technology.
Proposed acquisition of 51% of Black Axe Technologies in Poland marks strategic expansion.
Latest events from IM Cannabis
- Registering 17.3M shares for resale, with dilution risk and focus on German cannabis market.IMCC
Registration filing - Q1 2026 revenue reached $8.7M with a $2.5M net loss and ongoing cost optimization efforts.IMCC
Q1 2026 - Convertible note and warrant offering targets German growth but poses dilution and geopolitical risks.IMCC
Registration Filing - Seeking up to $50M for expansion, with focus on Germany and ongoing risks in Israel.IMCC
Registration Filing - Resale of nearly 5M shares enables capital for growth in Germany and Israel, with Nasdaq listing.IMCC
Registration Filing - Refocused on Germany’s medical cannabis market, with growth funded by recent private placements.IMCC
Registration Filing - Revenue up 12% and adjusted EBITDA loss down 82%, driven by German growth and efficiency.IMCC
Q3 2024 - German legalization drove a 129% sales surge and 12% revenue growth, but margins fell to 6%.IMCC
Q2 2024 - Q4 revenue rose 25% and Germany sales jumped 183%, leading to positive adjusted EBITDA.IMCC
Q4 2024